Evidence map›Paper›PMID 40528270›Full record

ArticleJournal of medical case reports2025

A case of rapidly growing conjunctival squamous cell carcinoma in a 3-year-old child with xeroderma pigmentosum: a case report.

Birhanu Kassie Reta, Micheale Hailu Weldegebriel, Hindeya Hailu Hagos, Nebiat Zerabiruk Embaye, Welday Tadesse Fisseha, Kibra Sebuh Kidanemariam

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Birhanu Kassie RetaDepartment of Pathology, Aksum University College of Health Science and Medicine, 7080, Aksum, Ethiopia. birexkassie24@gmail.com.
Micheale Hailu WeldegebrielDepartment of Ophthalmology, Aksum University College of Health Science and Medicine, Aksum, Ethiopia.
Hindeya Hailu HagosDepartment of Pediatrics and Child Health, Aksum University College of Health Science and Medicine, Aksum, Ethiopia.
Nebiat Zerabiruk EmbayeDepartment of Pathology, Aksum University College of Health Science and Medicine, 7080, Aksum, Ethiopia.
Welday Tadesse FissehaDepartment of Ophthalmology, Aksum University College of Health Science and Medicine, Aksum, Ethiopia.
Kibra Sebuh KidanemariamDepartment of Dermatovenereology, Aksum University College of Health Science and Medicine, Aksum, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundXeroderma pigmentosum is a rare autosomal recessive disorder characterized by hypersensitivity to ultraviolet light owing to mutation of nucleotide excision repair genes. Cutaneous and ocular malignancies commonly occur in the first decade of life in patients with xeroderma pigmentosum. Squamous cell carcinoma is the most common ocular malignancy in xeroderma pigmentosum. This case report aims to highlight that ocular malignancy can occur as early as the first few years of age in xeroderma pigmentosum, and the malignancies can progress rapidly unless early intervention is made. PRESENTATION OF CASE: We present a case of a 3-year-old male child from Tigray, Ethiopia, who is born to consanguineous parents and presented with right eye swelling and photophobia of 1-month duration. On physical examination, there was a fungating, ulcerated mass over the right palpebral conjunctiva and dry lentigos, scaly skin with poikiloderma over his face, neck, hands, and leg. A clinical diagnosis of xeroderma pigmentosum was made on the basis of history and cutaneous manifestations, and histopathologic examination of the conjunctival mass confirmed squamous cell carcinoma with orbital soft tissue extension.

conclusionOcular malignancies are disabling manifestations of xeroderma pigmentosum that usually occur in the first decade of life. Patients with xeroderma pigmentosum should be strongly advised on lifetime protection against ultraviolet light exposure, vitamin D supplementation, and frequent dermatologic and ophthalmologic examination to detect and treat early-stage malignancies. Delayed diagnosis of ocular malignancies may result in more aggressive management such as enucleation and exenteration.

Indexed as

Carcinoma, Squamous CellConjunctival NeoplasmsXeroderma PigmentosumChild, PreschoolHumansMaleCase reportConjunctivaPhotosensitivitySquamous cell carcinomaXeroderma pigmentosum

Identifiers

PMID40528270
PMCPMC12172206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.